While the latest variant, called Cicada, carries more mutations, it’s still part of the Omicron family that emerged in 2021.

Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a ...

But while Ozempic is arguably the most recognizable drug in its class, it isn’t the only medication approved for weight ...

Novo Nordisk is positioned as a durable No. 2 in the obesity drug market, not a loser to Eli Lilly. Click here to read an ...

Alison Law has revealed how Mounjaro weight-loss jabs took a toll on her health, admitting she didn't realise the impact ...

People with pre-existing depression or anxiety were less likely to have mental health worsening while taking a GLP-1 ...

In the battle of the obesity bulge, glucagon-like peptide-1 receptor agonist medications — aka GLP-1s such as Wegovy and Zepbound — have changed the game for some people who've struggled to ...

A new study found that people with depression and anxiety who used GLP-1 drugs like Ozempic and Wegovy had a 42% lower risk ...

LifeStance Health reports GLP-1 medications, known for weight loss, may also enhance mental health by improving mood, ...

After years of trying diets that never stuck for more than three months, Deborah Pasha’s weight hit 17.7 stone. She avoided ...

Ozempic and other GLP-1 weight-loss medications are being heralded as a miracle drug — and they likely are for people with ...

In a new GLP-1 study, semaglutide appeared to reduce the incidence of mental-health sick days and hospitalization, suggesting improved mood.